Tirzepatide Medical Weight Loss Program

We are able to offer a virtual program to Georgia residents or to individuals who are willing to travel to our office in Monroe, Georgia for an initial visit. We also refer out and consult with a medical provider who is able to offer virtual programs in South Carolina and Indiana. Please email WeightLoss@ourfamilyhealthcenter.com if you are interested in our virtual program.

Effectiveness is always going to come down to what works for an individual. A customized plan that begins with a medical evaluation of your overall health and includes ongoing monitoring and support with accountability is important to consider. Our Family Health offers both in our weight loss programs. Please listen to our podcast episode about the difference between Semaglutide and Tirzepatide for more information.

Alongside lifestyle modifications, Tirzepatide has the potential to help individuals reduce their weight by as much as 20%. It’s important to recognize that lifestyle factors such as getting adequate sleep, stress management, movement, and consuming nutrient-dense foods will be a part of any long-term successful weight-loss journey. Additionally, when use of the drug is discontinued, many patients gain back the weight they have lost. Our Program helps prevent this by working to motivate sustainable lifestyle changes and offering a maintenance program.

This program is not eligible for insurance coverage. Visits with medical providers are eligible for insurance coverage.

Tirzepatide is the generic name for the active ingredients in Mounjaro. Mounjaro was specifically approved by the FDA for the treatment of type 2 diabetes and is manufactured by Lilly.

While both Tirzepatide and Ozempic can aid in weight loss, they are not the same. Ozempic is Novo Nordisk’s tradename for the generic medication Semaglutide. Ozempic has been specifically approved for the treatment of type 2 diabetes.

Our Family Health offers a Semaglutide Medical Weight Loss program in addition to our Tirzepatide Medical Weight Loss Program.

Semaglutide is a GLP-1 agonist that can help to control appetite and increase feelings of fullness. Tirzepatide in contrast combines a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This combination makes Tirzepatide a more effective tool for some people.

Our Tirzepatide Medical Weight Loss program includes regular body composition scale measurements to obtain a comprehensive view into your body composition analysis to evaluate that you are losing fat, not muscle, and staying well hydrated. Our medical providers can then work with you to suggest additional movement and muscle building plans when indicated.

As with all medications, some users do experience side effects. The most common side effect experienced while taking Tirzepatide is stomach pain. Your medical team member will discuss all side effects with you before prescribing Tirzepatide and can work with you to navigate any GI-related side-effects.

Yes, we offer a maintenance program for people who have previously taken a GLP-1 either through Our Family Health or from another provider. This program offers two 5.0 mg injections of Tirzepatide two times a month (every 14 days) for $239/month. To enroll in this program, please contact 770-464-0280.

If you are new to GLP-1 prescriptions, the dosage for month one will be 2.5 mg, with a price of $329/month. For dosages above 2.5 mg and up to 12.5 mg, a price of $489/month will be applied. Therefore, if you have previously taken a GLP-1 and are transitioning to Tirzepatide at a dosage higher than 2.5 mg, you will pay $489/month.